Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema

Clinical trial NCT00375713 · COMPLETED

Trial details

NCT number: NCT00375713
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatitis Eczema

Start date: 2005-10-01
Primary completion: 2006-05-01
Enrollment: 466

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.